Objective To evaluate the clinical efficacy of Astragalus Injection and Astragalus Total-saponin Injection in Patients with angina pectoris. Methods Search the Cochrane Library， PubMed， CBM， CNKI， WanFang Data and VIP and collect information of randomized controlled trial（RCT） about the application of Astragalus Injection and Astragalus Total-saponin Sodium Chloride Injection in the treatment of Angina pectoris， building a database to retrieve the time to December， 2015. Two reviewers independently screened the literatures based on inclusion and exclusion criteria， and extracted information and evaluation methods including studies after methodology quality by use of software Rev Man 5.2.9 Meta-analysis. Results Meta-analysis showed that， compared with conventional western medicine treatment， Astragalus Injection associated with western medicine treatment could significantly improve the symptoms of angina［OR=3.67， 95% CI（2.42， 5.56）， P<0.001］and the electrocardiogram［OR=3.15， 95% CI（2.26， 4.41）， P<0.001］. The clinical efficacy of Astragalus Total-saponin Injection was comparative to that of Ligustrazine Sodium Chloride Injection（［OR=1.12， 95% CI（0.58， 2.15）， P=0.74］ and ［OR=1.15， 95% CI（0.63， 2.11）， P=0.64］， respectively）. When angina patients of Qi and Blood Stasis type were analyzed separately， it was shown that Astragalus Total-saponin Injection had similar efficacy in the improvement of traditional Chinese medicine syndromes with Ligustrazine Sodium Chloride Injection（P=0.81）. Conclusion Both Astragalus Injection and Astragalus Total-saponin Injection have significant effects in the treatment of angina pectoris. However， Due to the poor quality and the quantity limitation， he above conclusions still need to be verified through more large samples of high-quality RCT.